Patients with Intermediate Risk Prostate Cancer May be Good Candidates for Active Surveillance

In the recently updated AUA/ASTRO/SUO localized prostate cancer guidelines active surveillance was designated as an acceptable form of management for favorable intermediate risk prostate cancer.1 What is the evidence basis to support active surveillance for favorable intermediate risk prostate cancer and in what clinical context should this care option be considered?
Source: The Journal of Urology - Category: Urology & Nephrology Authors: Tags: Opposing Views Source Type: research